Delivery Order SPE2DB22D1106-SPE2DB25FEHD5

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,219.21 firm fixed-price delivery order is for APREPITANT 80 MG CAPSULE UD 6S, with a period of performance through January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,008.15, with a Firm Fixed Price pricing type. The award is for the provision of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract has an Ultimate Completion Date of June 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of APREPITANT 40 MG CAPSULE UDS. The contract is a Delivery Order with a Firm Fixed Price of $1,984.41 and a period of performance through June 25, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, on June 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,517.22 firm-fixed-price delivery order is for the supply of 4562584778 APREPITANT 40 MG CAPSULE UD 5S, with an ultimate completion date of October 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.40 firm fixed-price delivery order is for the supply of the medication Aprepitant 125-80-80 mg pack. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,321.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award, valued at $15,547.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of April 23, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,000.84 firm-fixed-price delivery order is for the supply of ACCRUFER 30 MG CAPSULE 60S, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $362,058.40, is a delivery order with a firm fixed price. It was awarded on April 21, 2025 and has an ultimate completion date of April 22, 2025. The contract is not set aside and is for the provision of a variety of pharmaceutical products and medical supplies to support military healthcare programs....
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEHD5
    Delivery Order

This federal contract award, valued at $7,093.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567873449 - APREPITANT 40 MG CAPSULE UD 5S, and has a firm fixed price pricing type with an ultimate completion date of April 11, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This prime contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 7/17/25, 6:11 PM